IN2012DN02401A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02401A
IN2012DN02401A IN2401DEN2012A IN2012DN02401A IN 2012DN02401 A IN2012DN02401 A IN 2012DN02401A IN 2401DEN2012 A IN2401DEN2012 A IN 2401DEN2012A IN 2012DN02401 A IN2012DN02401 A IN 2012DN02401A
Authority
IN
India
Prior art keywords
mutated
gene
tsp
protein
ptr
Prior art date
Application number
Inventor
Mark Ellis
David Paul Humphreys
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0916821A external-priority patent/GB0916821D0/en
Priority claimed from GBGB0916822.0A external-priority patent/GB0916822D0/en
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Publication of IN2012DN02401A publication Critical patent/IN2012DN02401A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A recombinant gram-negative bacterial cell comprising one or more of the following mutated protease genes: a. a mutated Tsp gene, wherein the mutated Tsp gene encodes a Tsp protein having reduced protease activity or is a knockout mutated Tsp gene; b. a mutated ptr gene, wherein the mutated ptr gene encodes a Protease III protein having reduced protease activity or is a knockout mutated ptr gene; and c. a mutated DegP gene encoding a DegP protein having chaperone activity and reduced protease activity ; wherein the cell is isogenic to a wild-type bacterial cell except for the mutated Tsp gene and/or mutated ptr gene and/or mutated Deg P gene and optionally a polynucleotide sequence encoding a protein of interest.
IN2401DEN2012 2009-09-24 2010-09-23 IN2012DN02401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0916821A GB0916821D0 (en) 2009-09-24 2009-09-24 Bacterial host strain
GBGB0916822.0A GB0916822D0 (en) 2009-09-24 2009-09-24 Bacterial host strain
PCT/GB2010/001790 WO2011036454A1 (en) 2009-09-24 2010-09-23 Bacterial host strain

Publications (1)

Publication Number Publication Date
IN2012DN02401A true IN2012DN02401A (en) 2015-08-21

Family

ID=43003459

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2401DEN2012 IN2012DN02401A (en) 2009-09-24 2010-09-23

Country Status (21)

Country Link
US (3) US9109216B2 (en)
EP (2) EP2480661A1 (en)
JP (2) JP6132551B2 (en)
KR (1) KR101758942B1 (en)
CN (1) CN102575241B (en)
AU (2) AU2010299640B2 (en)
BR (1) BR112012006670B8 (en)
CA (1) CA2774692C (en)
CY (1) CY1120947T1 (en)
DK (1) DK2993231T3 (en)
ES (1) ES2692811T3 (en)
HK (1) HK1172650A1 (en)
HR (1) HRP20181482T1 (en)
HU (1) HUE040306T2 (en)
IN (1) IN2012DN02401A (en)
LT (1) LT2993231T (en)
PL (1) PL2993231T3 (en)
PT (1) PT2993231T (en)
SG (1) SG10201606462WA (en)
SI (1) SI2993231T1 (en)
WO (1) WO2011036454A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101758942B1 (en) 2009-09-24 2017-07-17 유씨비 파마, 에스.에이. Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP3339325A1 (en) * 2011-07-13 2018-06-27 UCB Biopharma SPRL Bacterial host strain expressing recombinant dsbc
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
AU2020243460A1 (en) 2019-03-18 2021-10-07 Bio-Rad Abd Serotec Gmbh Protection of SpyTag-containing periplasmic fusion proteins from protease Tsp and ompT degradation
CN110616181A (en) * 2019-09-27 2019-12-27 北京理工大学 Engineering strain based on escherichia coli transformation
CN117965503A (en) * 2024-02-02 2024-05-03 南京迪诺薇华生物科技有限公司 Protease mutant and application thereof in skin-washing and caring products and cosmetics

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) * 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
WO1997038123A1 (en) 1996-04-05 1997-10-16 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP4249832B2 (en) * 1998-12-28 2009-04-08 タカラバイオ株式会社 Trigger factor expression plasmid
JP2003503074A (en) * 1999-06-29 2003-01-28 シガ・テクノロジーズ，インコーポレイテッド Analysis method for DEGP protease inhibitors
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
EP1314037A2 (en) 2000-09-01 2003-05-28 Biogen, Inc. Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
JP4309656B2 (en) 2000-12-14 2009-08-05 ジェネンテック・インコーポレーテッド Prokaryotic antibodies and their uses
NZ526134A (en) * 2000-12-14 2005-07-29 Genentech Inc E. coli strain deficient in degP and prc and having a mutant spr gene and a method for making a polypeptide
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
WO2003018771A2 (en) 2001-08-27 2003-03-06 Genentech, Inc. A system for antibody expression and assembly
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
EA007905B1 (en) 2001-11-16 2007-02-27 Байоджен Айдек Инк. Polycistronic expression of antibodies
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
ATE328906T1 (en) 2002-06-28 2006-06-15 Domantis Ltd DUAL-SPECIFIC LIGANDS WITH INCREASED HALF-LIFE
AU2003287345A1 (en) 2002-10-31 2004-06-07 Genentech, Inc. Methods and compositions for increasing antibody production
ATE528648T1 (en) 2002-12-03 2011-10-15 Ucb Pharma Sa METHOD FOR DETECTING ANTIBODY PRODUCING CELLS
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
KR20120090094A (en) 2003-06-13 2012-08-16 바이오겐 아이덱 엠에이 인코포레이티드 Aglycosyl anti-cd154(cd-40 ligand) antibodies and uses thereof
AU2004220325B2 (en) 2003-06-30 2011-05-12 Domantis Limited Polypeptides
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
WO2005011376A2 (en) 2003-07-26 2005-02-10 Biogen Idec Ma Inc Altered antibodies having improved antigen-binding affinity
EP1791563A4 (en) 2004-07-26 2009-07-08 Biogen Idec Inc Anti-cd154 antibodies
WO2006028936A2 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
TWI417299B (en) 2007-03-22 2013-12-01 Biogen Idec Inc Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
WO2008126785A1 (en) * 2007-04-06 2008-10-23 Kyowa Hakko Kirin Co., Ltd. Method of producing useful substance
US7741088B2 (en) * 2007-10-31 2010-06-22 E.I. Dupont De Nemours And Company Immobilized microbial nitrilase for production of glycolic acid
JP5217780B2 (en) * 2008-02-08 2013-06-19 味の素株式会社 Microorganism producing L-amino acid and method for producing L-amino acid
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
KR101758942B1 (en) * 2009-09-24 2017-07-17 유씨비 파마, 에스.에이. Bacterial host strain
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
US8361744B2 (en) 2009-11-05 2013-01-29 Genentech, Inc. Methods and composition for secretion of heterologous polypeptides
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000588D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
EP3339325A1 (en) 2011-07-13 2018-06-27 UCB Biopharma SPRL Bacterial host strain expressing recombinant dsbc
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
PT2993231T (en) 2018-11-12
EP2993231A3 (en) 2016-05-11
CY1120947T1 (en) 2019-12-11
SI2993231T1 (en) 2018-10-30
DK2993231T3 (en) 2018-10-22
US9315770B2 (en) 2016-04-19
BR112012006670A2 (en) 2015-09-08
WO2011036454A1 (en) 2011-03-31
ES2692811T3 (en) 2018-12-05
EP2993231B1 (en) 2018-08-01
US20160200810A1 (en) 2016-07-14
SG10201606462WA (en) 2016-09-29
HUE040306T2 (en) 2019-03-28
KR101758942B1 (en) 2017-07-17
US9550973B2 (en) 2017-01-24
BR112012006670B8 (en) 2022-03-03
LT2993231T (en) 2018-11-12
US20150344840A1 (en) 2015-12-03
JP2013505714A (en) 2013-02-21
EP2993231A2 (en) 2016-03-09
US9109216B2 (en) 2015-08-18
US20120258492A1 (en) 2012-10-11
CA2774692C (en) 2017-12-19
EP2480661A1 (en) 2012-08-01
JP2016116517A (en) 2016-06-30
JP6132551B2 (en) 2017-05-24
BR112012006670B1 (en) 2021-08-03
AU2010299640A1 (en) 2012-04-12
AU2010299640B2 (en) 2016-02-25
HK1172650A1 (en) 2013-04-26
CN102575241A (en) 2012-07-11
CA2774692A1 (en) 2011-03-31
PL2993231T3 (en) 2019-01-31
AU2016201536A1 (en) 2016-03-24
KR20120083435A (en) 2012-07-25
CN102575241B (en) 2016-02-24
HRP20181482T1 (en) 2018-11-02

Similar Documents

Publication Publication Date Title
IN2012DN02401A (en)
CY1122174T1 (en) BACTERIAL HOST STRAIN CONTAINING A MUTANT SPR GENE AND A WILD-TYPE TSP GENE
CY1118990T1 (en) BACTERIAL host strain expressing recombinant DSBC and has reduced TSP activity
MX2012013037A (en) Endoribonuclease compositions and methods of use thereof.
RS54084B1 (en) Bacterial host strain comprising a mutant spr gene and having reduced tsp activity
MY157111A (en) Recombinant microorganisms and methods of production thereof
NZ601241A (en) Improving activity of fe-s cluster requiring proteins
NZ733709A (en) Clostridium histolyticum enzymes and methods for the use thereof
MY186219A (en) Production of proteins in glutamine-free cell culture media
NZ607627A (en) Mutated protoporphyrinogen ix oxidase (ppx) genes
EP2539446A4 (en) A25 bacteriophage lysin
MX349517B (en) Polypeptides having protease activity and polynucleotides encoding same.
MX357457B (en) Method for evaluating bacterial cell wall integrity.
GB201000588D0 (en) Bacterial host strain
SG195180A1 (en) Method for detecting disease biomarkers
MX343699B (en) Dna expression construct.
MX2013008252A (en) Prognostic signature for colorectal cancer recurrence.
MX350391B (en) Polypeptides having protease activity and polynucleotides encoding same.
GB201021499D0 (en) Detection of quantative genetic differnces
MX2014007446A (en) Subtilase variants and polynucleotides encoding same.
WO2013096683A3 (en) Enhanced production of isoprene using marine bacterial cells
MY159439A (en) Method for producing glucosidase, enzyme composition, and method for hydrolyzing biomass
WO2008148932A3 (en) Glycosylasparaginase for treatment of cancers or inflammatory diseases
EA201291159A1 (en) PLANTS OF THE GENUS BRASSICA WITH MODIFIED CONSTRUCTION
MX2012005380A (en) Secretory protein biomarkers for high efficiency protein expression.